• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

    FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

  2. Roxgold named one of the TSX Venture's Top 50® companies

    Roxgold named one of the TSX Venture's Top 50® companies

  3. Roxgold Provides Financing Update for The Yaramoko Gold Project

    Roxgold Provides Financing Update for The Yaramoko Gold Project

  4. Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics

    Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics

  5. Roxgold announces receipt of mining decree for the Yaramoko Gold Project

    Roxgold announces receipt of mining decree for the Yaramoko Gold Project

  6. Genentech’s Phase III Study of Gazyva® Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma

    Genentech’s Phase III Study of Gazyva® Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma

  7. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Cancer Immunotherapy MPDL3280A (Anti-PDL1) in Non-Small Cell Lung Cancer

    FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Cancer Immunotherapy MPDL3280A (Anti-PDL1) in Non-Small Cell Lung Cancer

  8. Roche Gets U.S. Fast-Track Approval for Cancer Treatment

    Roche Gets U.S. Fast-Track Approval for Cancer Treatment

  9. Roche and Qualcomm Collaborate to Innovate Remote Patient Monitoring

    Roche and Qualcomm Collaborate to Innovate Remote Patient Monitoring

  10. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.